Latest filing published 14 Mar 2022 for INOVIO PHARMACEUTICALS, INC., €116k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 21 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +180.5%Entry US$39.48 · Close at T+365 US$110.76
- -21.5%Entry US$112.68 · Close at T+365 US$88.44
- -0.4%Entry US$120.96 · Close at T+365 US$120.48
- +515.7%Entry US$24.48 · Close at T+365 US$150.72
- +505.2%Entry US$27.84 · Close at T+365 US$168.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jong Joseph Kim: trading record in brief
Jong Joseph Kim is a declared insider of Inovio Pharmaceuticals, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 102 filings cover trades dated from 16 June 2011 to 11 March 2022.
On the open market, the record shows 24 purchases worth €2.0M and 15 sales worth €11.0M. Netting one side against the other leaves €8.9M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 24 share grants and 30 option exercises.
Half of the purchases are above €11k and half below. Looking at 21 purchases old enough to measure, the stock rose over the following 90 days in 38% of cases; the median change was -25.8%. This is a record of the past, not a forecast.
On 14 March 2022 came the latest disclosure, a share grant for €116k in Inovio Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,491 days ago, on 13 January 2020. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jong Joseph Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 39,698 shares@ US$3.220.6% of flowCommon StockSEC:0001055726-22-000020:1
- 139,387 sharesCommon StockSEC:0001055726-22-000020:0
- 18,142 shares@ US$3.260.3% of flowCommon StockSEC:0001055726-22-000016:1
- 63,700 sharesCommon StockSEC:0001055726-22-000016:0
- 20,045 shares@ US$3.220.3% of flowCommon StockSEC:0001055726-22-000009:1
- 68,767 sharesCommon StockSEC:0001055726-22-000009:0
- 74,545 shares@ US$10.573.6% of flowCommon StockSEC:0001055726-21-000024:1
- 139,387 sharesCommon StockSEC:0001055726-21-000024:0
- 64,230 shares@ US$9.192.7% of flowCommon StockSEC:0001055726-21-000022:1
- 34,067 shares@ US$8.911.4% of flowCommon StockSEC:0001055726-21-000022:3
- 120,100 sharesCommon StockSEC:0001055726-21-000022:0
- 63,700 sharesCommon StockSEC:0001055726-21-000022:2
- 100,000 shares@ US$15.006.7% of flowCommon StockSEC:0001055726-21-000008:0
- 62,500 shares@ US$4.561.3% of flowCommon StockSEC:0001055726-21-000008:1
- 62,500 shares@ US$14.244.0% of flowCommon StockSEC:0001055726-21-000008:2
- 10,000 shares0Common StockSEC:0001055726-20-000057:0
- 100,000 shares@ US$21.1365.8% of flowCommon StockSEC:0001055726-20-000045:0
- 36,826 shares@ US$5.706.8% of flowCommon StockSEC:0001055726-20-000017:1
- 105,700 sharesCommon StockSEC:0001055726-20-000017:0
- 37,371 shares@ US$9.8012.2% of flowCommon StockSEC:0001055726-20-000008:1
- 27,697 shares@ US$14.0912.9% of flowCommon StockSEC:0001055726-20-000008:3
- 120,100 sharesCommon StockSEC:0001055726-20-000008:0
- 63,700 sharesCommon StockSEC:0001055726-20-000008:2
- 22,500 shares@ US$3.110.8% of flowCommon StockSEC:0001055726-20-000002:0Canonical exit: 12 Apr 2020 (T+90)
- 500,000 shares@ US$2.4411.1% of flowCommon StockSEC:0001055726-19-000046:0
25 of 97 declarations
